Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal hematological malignant condition and the implications of pretreatment risk criteria as predictive or prognostic factors are constantly under evaluation. With this study, the authors' intent was to characterize AML patients and to evaluate the clinical o...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and clinical oncology 2017-03, Vol.6 (3), p.384-388
Main Authors: Espirito Santo, Ana, Chacim, Sergio, Ferreira, Isabel, Leite, Luis, Moreira, Claudia, Pereira, Dulcineia, Dantas, Margarida, Nunes, Marta, Viterbo, Luisa, Moreira, Ilidia, Martins, Angelo, Oliveira, Isabel, Domingues, Nelson, Mariz, Jose, Medeiros, Rui
Format: Article
Language:English
Subjects:
Acute myelocytic leukemia
Age
Analysis
Bone marrow
Care and treatment
Chromosomes
Confidence intervals
Cytogenetics
Gender
Leukemia
Medical prognosis
Morphology
Oncology
Patients
Prognosis
Stem cells
Studies
Treatment outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute myeloid leukemia (AML) is a clonal hematological malignant condition and the implications of pretreatment risk criteria as predictive or prognostic factors are constantly under evaluation. With this study, the authors' intent was to characterize AML patients and to evaluate the clinical outcome associated with Southwestern Oncology Group (SWOG) coding pretreatment risk criteria/cytogenetic score. Between 2002 and 2010, 225 patients were diagnosed with AML at the Portuguese Institute of Oncology (Porto, Portugal). From this patient group, 128 patients aged
ISSN:2049-9450
2049-9469
DOI:10.3892/mco.2017.1134